Telomere capping is the essential function of telomeres. To identify new genes involved in telomere capping, we carried out a genome-wide screen in Saccharomyces cerevisiae for suppressors of cdc13-1, an allele of the telomerecapping protein Cdc13. We report the identification of five novel suppressors, including the previously uncharacterized gene YML036W, which we name CGI121. Cgi121 is part of a conserved protein complex-the KEOPS complex-containing the protein kinase Bud32, the putative peptidase Kae1, and the uncharacterized protein Gon7. Deletion of CGI121 suppresses cdc13-1 via the dramatic reduction in ssDNA levels that accumulate in cdc13-1 cgi121 mutants. Deletion of BUD32 or other KEOPS components leads to short telomeres and a failure to add telomeres de novo to DNA double-strand breaks. Our results therefore indicate that the KEOPS complex promotes both telomere uncapping and telomere elongation.
INTRODUCTION
The ends of eukaryotic chromosomes are protected from degradation by a nucleoproteic structure called the telomere (d'Adda di Fagagna et al., 2004; Lydall, 2003) . In addition to its essential cellular function in chromosome-end protection, the telomere organizes chromosome-end replication in part by regulating the recruitment of telomerase, an enzyme minimally consisting of an RNA component and a reverse-transcriptase enzyme (Taggart and Zakian, 2003) . Telomerase catalyzes the addition of tandem G-rich repeats at the 3 0 end of linear chromosomes-TTAGGG in vertebrates and TG [1] [2] [3] in the budding yeast Saccharomyces cerevisiae.
In yeast, telomerase recruitment is mediated by the Cdc13-Ten1-Stn1 complex and the Yku70/80 heterodimer, both of which help to recruit telomerase via direct physical interactions with its components (Pennock et al., 2001; Stellwagen et al., 2003) . Cdc13 is an OB foldcontaining protein that directly binds TG-rich telomeric single-stranded (ss) DNA (Lin and Zakian, 1996; Nugent et al., 1996) . Thus, a critical step in Cdc13 and subsequent telomerase recruitment involves the generation of an ssDNA 3 0 overhang at chromosome ends. A number of studies have underscored the role of the Mre11-Rad50-Xrs2 (MRX) complex as a critical regulator of 3 0 overhang generation and of Cdc13 recruitment (Diede and Gottschling, 2001; Larrivee et al., 2004) .
Cdc13 and Yku70/Yku80 also play a critical role in chromosome end protection (Cervantes and Lundblad, 2002) . Cells expressing mutant forms of the Cdc13 complex or harboring deletions of YKU70/80 cannot adequately protect the telomeric CA-rich strand from nucleolytic degradation (Garvik et al., 1995; Maringele and Lydall, 2002) . The telomere-capping function of these proteins is separable from their telomere-elongation function but the fact that these two activities are derived from a single polypeptide suggests that both actions may be tightly coordinated. At restrictive temperatures, strains carrying cappingdefective alleles of these genes generate large amounts of ssDNA at telomeres and initiate a robust DNA-damage checkpoint response that is dependent on MEC1 and RAD9 (Garvik et al., 1995; Maringele and Lydall, 2002) . In addition to inducing checkpoint arrest and ensuing replicative senescence (in human cells; d'Adda di Fagagna et al., 2003) defects in telomere capping are a potent threat to genome stability (DuBois et al., 2002; Hackett et al., 2001) .
Deletion either of genes encoding DNA-damage checkpoint components (RAD9, MEC1, RAD24) or the gene encoding the 5 0 -3 0 exonuclease Exo1 suppress the checkpoint arrest imparted by telomere-capping defects (Lydall, 2003) . Checkpoint deficiency allows for continuous cell division despite the accumulation of ssDNA at uncapped chromosome ends (Garvik et al., 1995; Maringele and Lydall, 2002) , whereas deletion of EXO1 curtails the generation of ssDNA, thus guarding against the formation of a signal for checkpoint activation (Bertuch and Lundblad, 2004; Hackett and Greider, 2003; Maringele and Lydall, 2002; Zubko et al., 2004) . Telomere-capping defects associated with the cdc13-1 allele can also be partially suppressed by overexpression of the Stn1 protein, which interacts directly with Cdc13 (Grandin et al., 1997) . This effect was also recently observed in strains with an abrogated nonsense-mediated pathway of mRNA decay (NMD pathway). In NMD-deficient strains, the increased stability of STN1 transcripts results in a corresponding increase in Stn1 protein levels which, in turn, is able to suppress the capping defect of cdc13-1 (Enomoto et al., 2004) . Intriguingly, NMD and telomere metabolism may be more intimately associated than previously thought, as the metazoan homolog of the telomerase subunit Est1 appears to play a dual role in NMD and telomere regulation (Chiu et al., 2003; Reichenbach et al., 2003; Snow et al., 2003) .
The exact nature of what constitutes a capped telomere, the events that initiate progressive DNA resection as a consequence of telomere dysfunction, and how telomere capping may affect telomere elongation remain largely unknown. In this study, we sought to identify novel regulators of telomere structure in budding yeast using a genome-wide functional genomics screen to isolate genetic suppressors of the thermosensitive cdc13-1 allele. We report the isolation of five suppressors of cdc13-1 and the detailed characterization of one of these, the CGI121 (YML036W) gene. We show that Cgi121 functions in a genetic pathway with and interacts physically with an atypical and evolutionarily conserved protein kinase, Bud32 within the KEOPS complex (for kinase, putative endopeptidase and other proteins of small size). The KEOPS complex acts as a critical regulator of telomere elongation at native telomeres and at DSBs as well as to promote telomere uncapping in cdc13-1 strains. This dual role of the KEOPS complex appears unique among telomeric proteins and suggests that this conserved protein kinase-containing complex links the processes of telomere protection with telomere elongation.
RESULTS
To identify novel regulators of telomere metabolism or of the checkpoint response to dysfunctional telomeres, we employed synthetic genetic array (SGA) technology to introduce the cdc13-1 mutation into a set of $4800 nonessential gene-deletion strains constructed in the S288c strain background (Tong et al., 2001 ; Figure 1A ). These double-mutant strains were subsequently screened to identify those with the ability to grow at 27.5ºC, nearly 2ºC above the maximum permissive temperature for cdc13-1 strains. Using this approach, we recovered 9 of 11 expected null suppressors from the checkpoint and NMD pathways, indicating that the screen was successful in identifying known cdc13-1 suppressors (see Table S1 in the Supplemental Data available with this article online).
We have thus far confirmed five novel suppressors of the cdc13-1 capping defect, as tested in serial dilutions assays in the W303 genetic background: the pif1D, ebs1D, bmh1D, san1D, and yml036D mutations (Figure 1B) . PIF1 encodes a helicase that functions as a negative regulator of telomerase (Boule et al., 2005; Schulz and Zakian, 1994) . EBS1 codes for an Est1 paralog, and ebs1D cells have a short-telomere phenotype, suggesting a role in normal telomere metabolism (Zhou et al., 2000) . BMH1 encodes a member of the 14-3-3 family of proteins that are phosphoserine binding proteins involved in a number of signaling processes, including checkpoint signaling (Lottersberger et al., 2003) . San1 encodes an E3 ubiquitin ligase that functions to target misfolded nuclear proteins for destruction, and its deletion stabilizes the Cdc13-1 protein (Gardner et al., 2005) . Finally, YML036W encodes a previously uncharacterized gene product of a predicted molecular weight of 21.8 kDa with no recognizable domains or motifs. YML036W is highly conserved in eukaryotes, with the exception of Drosophila ( Figure S1 ). The human homolog of YML036W is known as CGI-121 and was identified in a two-hybrid screen using the putative p53 protein kinase PRPK as bait (Miyoshi et al., 2003) . We propose to give the name CGI121 to the YML036W ORF to reflect this relationship.
Given its evolutionary conservation and its poorly understood function, we focused our attention on the role of CGI121 in telomere metabolism. To determine whether cgi121D is able to suppress the telomerecapping defects of a YKU deletion or of CDC13 alleles other than cdc13-1, we introduced the cgi121D mutation into cells carrying the yku70D mutation and the temperature-sensitive ssDNA binding defective allele of CDC13, cdc13-6 (Hughes et al., 2000) . As shown in Figure 2A , cgi121D yku70D double mutants are able to grow at 37ºC, whereas yku70D cells are inviable at this temperature. Likewise, the cgi121D mutation results in the suppression of cdc13-6 temperature sensitivity at 34ºC ( Figure 2B ). These observations demonstrate that the cgi121D mutation does not solely suppress cdc13-1 and can suppress other temperature-sensitive defects caused by loss of telomere capping.
The cgi121D Mutation Suppresses ssDNA Accumulation in the cdc13-1 Strain Deficiencies in checkpoint signaling and the NMD pathway can both increase the cdc13-1 restrictive temperature. We therefore assessed whether Cgi121 is a component of either of these pathways. To determine whether the cgi121D mutation affects the checkpoint response to dysfunctional telomeres, we introduced the cgi121D mutation into cdc13-1 cdc15-2 strains (Lydall and Weinert, 1995) . At 36ºC, cgi121D cdc13-1 cdc15-2 strains arrest at metaphase within the first round of cellular division, as would be expected for cells proficient in checkpoint signaling, despite a delay in progression through the cell cycle ( Figures 2C and 2D) . In stark contrast, a rad9D cdc13-1 cdc15-2 strain fails to accumulate at metaphase and arrests instead in telophase, at the cdc15-2 arrest point (Figures 2C and 2D ). We therefore conclude that CGI121 is not directly involved in the checkpoint response to dysfunctional telomeres.
Secondly, we tested whether Cgi121 was involved in the NMD pathway by examining the levels of the NMDsensitive Stn1 protein (Enomoto et al., 2004) or by examining the abundance of the CYH2 pre-mRNA, a direct target of the NMD pathway (He et al., 1993) . As shown in Figure S2 , two different cgi121D isolates fail to show the dramatic increase in Stn1 or CYH2 pre-mRNA levels observed in upf2D cells. In addition, upf2D cgi121D double mutants are more potent suppressors of cdc13-1 temperature sensitivity than either single mutant (data not shown), suggesting that these genes are not epistatic and function instead within different genetic pathways. Hence, we conclude that Cgi121 is not directly involved in the NMD pathway.
Thirdly, we sought to examine whether strains carrying the cdc13-1 and cgi121D mutations accumulate RAD52-dependent ''survivors'' showing the amplification of telomeric repeats characteristic of telomerase-deficient cells Lundblad and Blackburn, 1993) . Such telomeric recombination events can support the growth of cdc13-1 cells at elevated temperatures (Grandin et al., 2001) . As shown in Figure S2C , cgi121D cdc13-1 strains do not show amplification of either Y-or TG-tract repeats characteristic of survivors. In addition, deletion of RAD52 does not affect the extent of cdc13-1 suppression by the cgi121D mutation (data not shown), indicating that the suppression of cdc13-1 temperature sensitivity cannot be explained by the accumulation of ''survivors.'' Lastly, we tested directly whether the cgi121D mutation reduced the amount of ssDNA detected in cdc13-1 mutants near telomeres. In cdc13-1 mutants, ssDNA is generated in a telomere-to-centromere direction, with Rad24 and Exo1 being required for ssDNA production while Rad9 inhibits ssDNA production (Booth et al., 2001; Zubko et al., 2004) . As shown in Figures 2F-2H , when asynchronously dividing cdc13-1 cultures are shifted at restrictive temperature (28ºC), ssDNA accumulates specifically on the 3 0 TG strand, but not the 5 0 AC strand, at loci 600 bp or 8.5 kb away from the chromosome end. As expected, deletion of EXO1 in these strains severely curtails the accumulation of ssDNA at both loci and close to the background levels seen in the CDC13 + strain, at the 8.5 kb locus. Interestingly, we find that deletion of CGI121 results in a similar inhibition of ssDNA generation at both loci, indicating that the cgi121D is a potent suppressor of ssDNA accumulation in cdc13-1 mutants at 28ºC. This suppression of ssDNA accumulation correlates with the suppression of cdc13-1 thermosensitivity and indicates that loss of Cgi121 from yeast cells suppresses cdc13-1 thermosensitivity by limiting the amount of ssDNA generated at uncapped telomeres. (A) Schematic depiction of the screen. The DLY2304 strain containing a cdc13-1 allele flanked by URA3 and LEU2 genes was mated to an arrayed set of $4800 MATa haploid deletion mutants, each carrying a different null mutation linked to the KANMX marker. Following sporulation, haploid cells were selected by using a MATa-specific promoter driving transcription of the HIS3 gene. The resulting double-mutant strains were then grown in liquid cultures and spotted on agar plates to test their ability to grow at temperatures permissive or restrictive for cdc13-1 growth. (B) Five-fold serial dilutions of the indicated strains were spotted onto rich media and grown for three days at the indicated temperatures.
Figure 2. Deletion of CGI121 Suppresses Telomere-Capping Defects
(A and B) Deletion of CGI121 suppresses the temperature-sensitive growth defects associated with the yku70D (A) and cdc13-6 (B) mutations. Serial dilutions of strains DDY663 (yku70D) DDY664 (cgi121D), DDY665 (cgi121D yku70D), DDY595 (cdc13-6), DDY673 (cdc13-6 rad9D), and DDY676 (cdc13-6 cgi121D) were spotted on rich media and grown for 3-5 days at the indicated temperatures. We noted that the suppression of yku appears specific to yku70D in S288C. (C and D) CGI121 is not involved in the checkpoint response to uncapped telomeres. cgi121D cdc13-1 cdc15-2 (DDY582) strains accumulate at the G2/M arrest point during the course of a single cell-cycle when cultured at 37ºC. Following release from G1 arrest, cells were stained with DAPI and examined by microscopy to score for the presence of large dumbbell-shaped cells containing a single nucleus (C) or two nuclei (D), indicative of metaphase or telophase arrest, respectively. (E-H) cgi121D cdc13-1 fail to accumulate ssDNA at telomeres. Cgi121 Interacts and Functions with the Bud32 Protein Kinase As described above, the human homolog of Cgi121, CG1-121, interacts with the putative p53 Ser15 kinase PRPK (Miyoshi et al., 2003) . Based on sequence homology, a clear PRPK ortholog can be identified in budding yeast, the previously named Bud32 ( Figure S1 ; Facchin et al., 2003) . Homozygous null mutants of BUD32 display a defect in bipolar budding pattern (Ni and Snyder, 2001 ), but the molecular basis for this defect is unknown. Bud32 is a nuclear protein and was found to interact with Cgi121 in a high-throughput protein-protein interaction study (Ho et al., 2002) , further supporting the notion that the hCGI-121/PRPK interaction may be conserved in yeast.
To test this possibility, we coexpressed epitope-tagged forms of Bud32 and Cgi121 and examined their ability to interact in coimmunoprecipitation experiments. Epitopetagged Bud32 (or native Bud32; data not shown) associates with HA-tagged Cgi121 ( Figure 3A ). Thus, consistent with the physical interaction of their human homologs, Bud32 and Cgi121 form a stable protein complex.
Next, we determined if a bud32D mutation could also suppress cdc13-1 temperature sensitivity. As shown in Figure 3B , the bud32D mutation is a potent suppressor of cdc13-1, being able to suppress cdc13-1 at temperatures up to 30ºC-32ºC. This level of suppression is especially remarkable given the fact that bud32D strains have a slow growth phenotype at these temperatures ( Figure 3B ; Facchin et al., 2002) . Since Bud32 is a protein kinase, we next examined whether the kinase activity of Bud32 was required for the apparent negative impact of Bud32 on telomere capping. We thus generated the bud32-K52A allele, which essentially abolishes the phosphotransferase activity of Bud32 (Facchin et al., 2002) and introduced it into cdc13-1 bud32D cells. As a control, the reintroduction of wild-type BUD32 abolishes the ability of the bud32D mutation to suppress cdc13-1 ( Figure 3C ). Thus, bud32D suppression of cdc13-1 temperature sensitivity is not due to a mutation unlinked to BUD32. In contrast, the kinase-dead allele of BUD32 does not abrogate the suppression of temperature sensitivity in cdc13-1 bud32D cells but does, however, greatly improve the growth of the bud32D strain. These results suggest that Bud32, like Cgi121, promotes telomere uncapping in budding yeast under conditions of telomere dysfunction and that the catalytic activity of the Bud32 kinase is required for the observed effect.
We found that both the ebs1D and pif1D mutations suppress cdc13-1 (Figure 1 ). Since deletion of these genes also alters telomere length, we measured average telomere length in strains containing the bud32D, cgi121D, or bud32D cgi121D mutations ( Figure 3D ). Strikingly, bud32D cells have dramatically shortened telomeres relative to wild-type strains. The short-telomere phenotype of bud32D strains is fully suppressed by reintroduction of a wild-type copy of BUD32 ( Figure 3E ) indicating that the defect of these strains is imparted by the loss of BUD32. The maintenance of normal telomere length by Bud32 also requires its kinase activity ( Figure 3E ) suggesting that Bud32 may modulate the activity of one or more telomere regulatory proteins via reversible protein phosphorylation.
In parallel with the observation that the cgi121D mutation is a weaker suppressor of cdc13-1 than the bud32D mutation, cgi121D cells also display shortened telomeres but to a lesser degree than those seen in bud32D cells ( Figure 3D ). Furthermore, BUD32 and CGI121 appear to function in the same pathway of telomere-length maintenance, since deletion of both CGI121 and BUD32 does not result in any further decrease in telomere length ( Figure 3D ).
Remarkably, telomeres in bud32D strains are as short as those in tel1D or yku70D strains ( Figure 4A ). However, BUD32 does not appear to participate in either the YKU or TEL1-dependent pathways of telomere maintenance as the bud32D yku70D and bud32D tel1D strains were both shorter than the single mutants ( Figure S3 ). We also observe that telomeres in cgi121D yku70D and cgi121D tel1D strains are shorter than either yku70D and tel1D strains, respectively (data not shown). Likewise, BUD32 (or CGI121) does not act in the PIF1 or RIF1 pathways of telomere elongation since telomere length in bud32D rif1D or bud32D pif1D strains is at an intermediary length between those of bud32D and either pif1D or rif1D strains, respectively ( Figure S3 ). However, we note that the telomere length of the pif1D bud32D strains are nearly that of the bud32D strains, perhaps indicating some functional overlap between those two genes. Finally, to determine whether BUD32 functions within the telomerase-dependent pathway of telomere maintenance we generated an est2D/EST2 bud32D/BUD32 diploid strain. After sporulation, the resulting congenic est2D, bud32D, and bud32D est2D strains were serially passaged to analyze the rate of cellular senescence. Deletion of genes functioning outside the telomerase pathway is expected to accelerate the senescence of telomerase-negative strains (Nugent et al., 1998) . However, BUD32 deletion does not accelerate the onset of senescence in est2D cells ( Figure 4B ), and bud32D est2D telomeres shorten at a rate comparable to est2D single mutants ( Figure 4C ). We therefore conclude that Bud32 functions predominantly within the telomerase-mediated pathway of telomere-length maintenance.
Cgi121 and Bud32 Are Part of the Larger KEOPS Complex As part of an ongoing large-scale study of the yeast interactome (N.J.K., A.E. and J.F.G., unpublished data), Bud32 and Cgi121 were found to be in a complex with Gon7 (Yjl184w) and Kae1 (Ykr038c) following tandem affinity purifications of Bud32-TAP, Gon7-TAP, and Kae1-TAP ( Figure 5A ). Grx4 and Grx3, two related glutaredoxins, were also found to associate with TAP-tagged Bud32 but not with Gon7-TAP or Kae1-TAP ( Figure 5A ), a result also supported by yeast two-hybrid and Flag-epitope immunopurifications (Ho et al., 2002; Lopreiato et al., 2004) . This observation may indicate that Bud32 is part of two complexes: a first one where Bud32 is bound to glutaredoxins and a second with Gon7, Cgi121, and Kae1. Gon7 is a small protein of unknown function, whereas Kae1 is a putative endopeptidase. Further supporting that the Kae1-Bud32 interaction has functional significance, some archaeal genomes encode a fusion of bacterial Kae1 and Bud32 homologs (Lopreiato et al., 2004) . To confirm these interactions, we immunoprecipitated TAP-tagged versions of Kae1, Gon7, or Grx4 and assayed for the presence of native Bud32 in the immunoprecipitates. As shown in Figure 5B , Bud32 is detected in Gon7 and Kae1 immunoprecipitates. However, we could not detect Bud32 in Grx4-immunoprecipitates, in contrast to the prior studies of Lopreiato et al. (2004) . A reason for this discrepancy may be that we used a C-terminally tagged Grx4 that might interfere with the Grx4-Bud32 interaction. Nevertheless, these results suggest that Bud32 forms a multiprotein complex with Cgi121, Kae1, and Gon7. Indeed, using gel filtration studies ( Figure S4 ), we find that Kae1 and Bud32 coelute and have hydrodynamic properties consistent (A) Bud32 and Cgi121 interact physically. Anti-HA immunoprecipitations were carried out in extracts prepared from strains DDY634, DDY638, or DDY632 grown in the presence of galactose. Bud32-FLAG and 3HA-Cgi121 were detected by mouse anti-FLAG M2 and anti-HA (clone 12CA5) antibodies, respectively. Ten percent of the whole-cell extract used in the immunoprecipitation was loaded as control. (B) bud32D mutants are potent suppressors of cdc13-1 temperature sensitivity. Five-fold serial dilutions of the DDY1199 (cdc13-1 bud32D), DDY1200 (bud32D), DDY1201 (cdc13-1) strains were spotted on rich media, and plates were incubated at the indicated temperatures for 3 days (30ºC and 34ºC) or 5 days (25ºC). (C) The role of Bud32 in telomere capping is mediated by its kinase activity. Plasmid DDp472 (pBUD32) or plasmid DDp473 (pbud32-K52A) were introduced in bud32D cdc13-1 cells (DDY723), and the ability of these strains to grow at temperatures restrictive for cdc13-1 was evaluated. (D) bud32D and cgi121D cells have short telomeres. Telomere length analysis of wild-type (DDY662), cgi121D (DDY762), bud32D (DDY763), and cgi121D bud32D (DDY765) strains. Lanes 4-9 represent strains passaged to single colonies six times after plasmid loss on 5-FOA media from cgi121D pCGI121, bud32D pBUD32, or stc1D bud32 pBUD32 strains. (E) Kinase-dead Bud32 does not support normal telomere length. TRF analysis of average telomere length in strains wild-type (S288c) strains, bud32D (DDY1230), or bud32D strains containing plasmid DDp472 (pBUD32) or plasmid DDp473 (pbud32-K52A).
with a multiprotein complex of approximately 400 kDa. Based on these observations, we suggest the name KEOPS to describe this complex (for kinase, putative endopeptidase and other proteins of small size).
Consistent with Bud32 and Cgi121 carrying out their functions as part of a larger complex containing Gon7 and Kae1, deletion of GON7 results in a large decrease in telomere length ( Figure 5C ). Since KAE1 is essential, we have not tested whether loss-of-function kae1 mutants also result in telomere-length defects. Nevertheless, our results are consistent with the KEOPS complex, as a whole, participating in the regulation of telomere metabolism.
BUD32 Is Essential for Telomere Healing
Telomere healing (also termed ectopic telomere addition) is a type of gross chromosomal rearrangement that occurs when telomerase acts on DSBs. Addition of a new telomere to a DSB almost invariably results in the loss of genetic information, and, in cells with haploid genomes, this type of chromosomal aberration is only tolerated when the telomere healing event occurs toward the end of a chromosome, in regions devoid of essential genes. Importantly, the mechanisms leading to ectopic telomere addition differ from telomere length homeostasis at native chromosome ends in one important regard: sequences surrounding DSBs generally lack the long double-stranded TG-repeat tracts bound by the Rap1/Rif1 proteins that are involved in telomere-length homeostasis. Therefore, telomere healing depends largely on the processing of the DNA end and the ensuing stepwise recruitment of Cdc13, followed by Est1 and associated telomerase components (Bianchi et al., 2004; Diede and Gottschling, 1999; Diede and Gottschling, 2001; Myung et al., 2001 ). To determine if BUD32 is involved in telomere healing, we took advantage of the GCR system developed by Kolodner et al. which examines the spontaneous loss of URA3 and CAN1 on Chr V-L ( Figure 6A ; Chen and Kolodner, 1999) . URA3 and CAN1 are markers that can be counterselected on 5-fluroro-orotic acid (5-FOA) and canavinine (CAN), respectively, and, in wild-type strains, these two markers are lost simultaneously at a rate of $2 Â 10 À10 (Chen and Kolodner, 1999) . In wild-type strains, cells that have undergone a GCR event, leading to loss of URA3 and CAN1, repair their spontaneously broken chromosomes mainly via nonreciprocal translocation and telomere healing, with a clear bias toward telomere healing (Chen and Kolodner, 1999). Interestingly, by virtue of its role as a negative regulator of telomerase, deletion of the gene encoding Pif1 allows for a dramatically increased rate of recovery of GCR events, with the great majority having undergone telomere healing (Mangahas et al., 2001; Myung et al., 2001 ). We therefore tested whether BUD32 was required for telomere healing of DSBs in pif1D ChrV CAN1-URA3 strains by performing GCR assays. As controls, we also examined the contribution of YKU70 and TEL1 to telomere healing in this context (Myung et al., 2001 ). As expected, we observed a dramatic reduction in the rate of GCR events observed in pif1D strains carrying a deletion of YKU70, consistent with its function in directly assisting with telomerase recruitment ( Figure 6B ; Myung et al., 2001; Stellwagen et al., 2003) . Deletion of TEL1 had little effect on the GCR rate of a pif1D strain, recapitulating the results of Myung et al. (2001) and confirming the dependence of Tel1 action on the presence of the Rap1/Rif proteins that bind to preexisting double-stranded TG repeats (Craven and Petes, 1999) . Remarkably, BUD32 deletion dramatically suppressed the mutation rate associated with pif1D -mediated telomere healing to levels slightly lower than the yku70D pif1D strain ( Figure 6B ). This result indicates that BUD32 has a role in ectopic telomere addition and suggests that the function of Bud32 may not depend on a preexisting telomere. Collectively, these results suggest that Bud32 may either regulate telomerase recruitment, telomerase activity, or may act downstream of Pif1 in the regulation of telomere elongation and healing events. To further delineate the requirement for Bud32 during telomere healing, independently of a pif1D deletion, we turned to a system recently described by Bianchi et al. (A) Identification of KEOPS components using mass spectrometry. Bud32-TAP, Gon7-TAP, or Kae1-TAP were purified by tandem affinity purification (Rigaut et al., 1999) , and associated proteins were purified using SDS-PAGE prior to identification using MALDI-TOF mass-spectrometry (bands labeled by arrows on the left panel) or analyzed without gel purification by LC-MS (right panel; X denotes positive identification by LC-MS). (B) Indicated TAP-tagged proteins were purified by immunoprecipitation and analyzed using SDS-PAGE, followed by Western analysis using an antiBud32 antibody. Ten percent of the input was loaded as control. (C) Telomere length in strains deleted for individual KEOPS components: bud32D (DDY1230), cgi121D (DDY664), grx4D (DDY1238), gon7D (DDY1239).
(2004) and schematized in Figure 6C . This system relies on the galactose-inducible expression of the HO endonuclease to create a DSB at a site near the end of chromosome VII-L. Like the GCR assay described above, this system monitors telomere-healing events via the loss of the DSB-distal markers URA3 or LYS2 (counterselected by 5-FOA and a-aminoadipate, respectively). At a position that is centromere proximal to the HO site are a series of tandem Gal4 DNA binding sites (UASg), which allow for the recruitment of proteins fused to the Gal4 DNA binding domain (GBD). Expectedly and as previously reported, we found that the percentage of cells undergoing telomere healing events was greatly stimulated by the expression of an Est1-GDB fusion protein, when compared with strains that express the GDB protein alone ( Figure 6D ). By stark contrast, a strain containing a BUD32 deletion is highly deficient in its ability to add telomeres to a DSB even when an Est1-GDB fusion is expressed ( Figure 6D ). These results suggest that Bud32 is not involved in the series of events that leads to Est1 recruitment, as its targeting by artificial means does not rescue the profound telomere healing defect of a bud32D strain.
BUD32 Is Required Downstream of Telomerase Recruitment
The profound telomere-healing defect of bud32D strains spurred us to test whether physical targeting of telomerase subunits to natural telomeres also requires Bud32 for efficient telomere elongation. We expressed in wildtype or bud32D cells fusion proteins covalently linking Est1, Est2, the catalytically inactive Est2 D670A mutant, and Est3 to Cdc13 (either full-length or its DNA binding domain; Evans and Lundblad, 1999; Pennock et al., 2001 ). These fusion proteins are able to elongate telomeres by Targeting of an Est1-GBD fusion protein to DSB sites increases telomere healing in wild-type (DDY1217) but not bud32D cells (DDY1222). Cells were grown in synthetic media lacking tryptophan and uracil but containing raffinose prior to addition of galactose. Cells were plated on rich media, and telomere-healing events were selected by replica plating on a-aminoadipate plates lacking adenine.
short-circuiting telomerase recruitment at telomeres. Accordingly, in wild-type cells, we observed that physically tethering Est1, Est2, or Est3 to telomeres results in telomere lengthening ranging from 357 to 604 bp after 75 generations ( Figures 7A and 7B ) while tethering the catalytically inactive Est2 mutant results in a slight telomereshortening phenotype (Figures 7A and 7B) . In sharp contrast, the same fusion proteins expressed in bud32D cells are severely defective in telomere elongation with lengthening averaging 3-43 bp only, after over 100 generations of growth ( Figures 7A and 7B ). These results suggest that Bud32 is required downstream of telomerase recruitment at chromosome ends. The failure of Cdc13-Est fusion proteins to promote telomere elongation in bud32D cells is somewhat reminiscent of the failure of Cdc13-Est2 to promote elongation in est1D cells (Evans and Lundblad, 1999) . In est1D cells expressing a Cdc13-Est2 fusion, telomeres do not elongate nor progressively shorten to trigger senescence. This data illuminated a poorly characterized activity of Est1 that may either concern telomerase activation (Taggart et al., 2002) or access to the 3 0 end of the chromosome (Evans and Lundblad, 1999) . We therefore sought to determine telomere length in an est1D bud32D double-mutant strain expressing the CDC13-EST2 fusion to assess whether BUD32 acts in the same pathway as EST1. As shown in Figure 7C , the telomeres of four generated bud32D est1D <CDC13-EST2> strains, although more heterogeneous than in Figure 7A , are at lengths similar to those observed in est1D <CDC13-EST2> cells. These results suggest that BUD32 may act in or overlap with the EST1 pathway of telomere elongation at a step downstream of telomerase recruitment.
One possible explanation for the profound effect of the BUD32 deletion on telomere-length homeostasis and telomere healing is that Bud32 is required for optimal telomerase activity. To test this possibility, we fractionated S100 extracts from wild-type, bud32D and est2D cells on DEAE Sepharose as described in Cohn and Blackburn (1995) and assayed for telomerase activity in these fractions by primer-extension assays. As shown in Figures  7D and S6 , extracts from bud32D cells show RNasesensitive telomerase activity that is almost identical to that of wild-type cells under the conditions tested. These results clearly indicate that Bud32 is not required for telomerase activity on synthetic primers, an activity that is independent of the Est1 and Est3 subunits under the conditions used. Collectively, these results are consistent with a model whereby Bud32 may be required for an activity of telomerase that is independent of recruitment.
DISCUSSION

Functional Genomic Analysis of Telomere Capping
The nature of what constitutes a ''protected'' chromosome end or how chromosome end-structure functionally impacts telomere length homeostasis is poorly understood. This question is fundamental to the understanding of how telomere erosion due to ageing is linked to genome instability and the development of malignancies. Using budding yeast, we have adapted synthetic genetic array technology (Tong et al., 2001 ) to identify novel gene deletions that increase the maximal permissive temperature of cdc13-1, a model for the loss of telomere capping. From this screen, we have identified six novel suppressors of cdc13-1 (including bud32D). Most of these suppressors suggest novel avenues of study related to telomere capping at the molecular level. For example, our finding that the deletion of PIF1 increases some aspect of telomere capping is intriguing given its proposed role as a negative regulator of telomerase (Boule et al., 2005) . If Pif1 affects the capping of telomeres via its influence on telomerase, our results would suggest that the telomerase-DNA interaction may somehow be involved in telomere capping, as previously suggested by the finding that overexpression of telomerase components suppress the temperature sensitivity of cdc13-1 and ykuD mutants (Nugent et al., 1998; Teo and Jackson, 2001 ). In addition, since Est1 proteins appear to have a 14-3-3 fold (Fukuhara et al., 2005) , our finding that the deletion of EBS1 or BMH1 suppresses cdc13-1 may suggest that phosphodependent proteinprotein interactions play an important role in the regulation of telomere capping in eukaryotes.
In this study, we focused our efforts on the characterization of the YML036W gene, which encodes a highly conserved protein of small size and of unknown function. We have given the name CGI121 to YML036W, to reflect its orthologous relationship with human hCGI-121. Four different assays were performed to assess the role of Cgi121 (or its interacting protein Bud32) in telomere biology: first, we found that Cgi121 and Bud32 appear to cooperate with the cdc13-1 mutation to promote telomere uncapping, as their deletion suppresses the temperature sensitivity of cdc13-1 via the abrogation of ssDNA generation at telomeres. Second, cells lacking individual KEOPS components (Gon7, Bud32, and Cgi121) display stable telomere shortening, indicating that they play a positive role in telomere elongation. Third, Bud32 is required for de novo addition of telomeres at DSBs. Fourth, Bud32 is required for the ability of telomere bound telomerase to elongate telomeres. Collectively, all these observations are consistent with a model whereby the KEOPS complex is a critical and novel regulator of telomere metabolism in eukaryotes.
A Model of KEOPS Complex Function at Telomeres
Any model attempting to explain the function of the KEOPS complex at telomeres must account for the fact that Bud32 and Cgi121 act both as positive regulators of telomere elongation and as promoters of telomere uncapping. The function of the KEOPS complex in telomere capping is likely to be solely manifest during conditions of telomere dysfunction as deletion of CGI121 does not have on its own a major impact on telomere capping as measured by a telomere-capture assay ( Figure S5 ; DuBois et al., 2002) . Whether these two different aspects (C) TRF analysis of est1D bud32D double-mutant cells expressing the CDC13-EST2 chimaeric gene. A wild-type strain expressing the Cdc13-Est2 fusion for 100 generations was deleted for EST1 (lanes 3 and 4), BUD32 (lanes 5 and 6), or for both EST1 and BUD32 (lanes 7-10). Strains underwent an additional 75 generations at the time of harvest. (D) In vitro telomerase activity is not affected by BUD32 deletion. Partially DEAE-purified protein fractions were prepared from wild-type (DDY1240), bud32D (DDY1241), and est2D (DDY1242) strains. Telomerase activity was detected as an RNase-sensitive activity in primer extension assays performed as described in Cohn and Blackburn (1995) . The absence of extension products in extracts prepared from est2D cells further indicates that the activity observed is due to telomerase. In vitro reconstituted human telomerase was used as a positive control.
of telomere regulation by the KEOPS complex are the fruit of a single biochemical activity remains to be specifically addressed. However, we note that a kinase-dead allele of BUD32 (bud32-K52A) displays both telomere shortening and cdc13-1 suppression, supporting the idea that both phenotypes are controlled by a single biochemical activity borne by the KEOPS complex.
In order to gain further insight into the mechanism by which the KEOPS complex affect telomeres, we sought to determine whether Bud32 is enriched at telomeres via chromatin immunoprecipitation ( Figure S7 ). Although our results are consistent with Bud32 being slightly enriched at telomeres, further work will be required to determine whether this localization is important for telomere regulation. In fact, as the KEOPS complex contains one or more enzymatic activity, it is plausible that a fleeting interaction between the KEOPS complex and telomeres is sufficient to have the profound impact on telomere homeostasis documented here.
From our observations we propose that the KEOPS complex regulates access to the chromosome end (Figure S8) . Although other models can explain our data, we favor this model as it is by far the simplest way to account for the observed functions of KEOPS components in the regulation of both telomere-length homeostasis and capping. In this model, an ''open'' telomere conformation is promoted by the KEOPS complex. This open state would allow both telomerase access and would promote exonuclease degradation of the chromosome end following telomere uncapping.
Importantly, since the targeted delivery of telomerase to the chromosome end does not cause significant telomere lengthening in bud32D cells ( Figure 7A ), we believe that the short telomere defect observed in KEOPS mutants is not, in large part, related to a failure in telomerase recruitment. Rather, the accessibility of the 3 0 end of the chromosome to Est2 may be limited in cells lacking BUD32. Interestingly, data from Evans and Lundblad (1999) suggest that Est1, in addition to its proposed role as a telomerase-targeting factor, possesses a secondary function required for telomere elongation; namely to promote accessibility to the chromosome 3 0 end. We are tempted to speculate that Bud32, by virtue of its demonstrated protein kinase activity, may regulate this Est1 function via protein phosphorylation. Remarkably, regulation of access to the chromosome 3 0 end can be easily imagined if a structure similar to the t loop exists in yeast (Griffith et al., 1999) . Indeed, such a structure would represent an attractive site for KEOPS action since t loops have been shown to link telomere-end protection and telomere elongation to the regulation of chromosome-end accessibility (de Lange, 2005) . Finally, an alternative model for our data can be elaborated in light of the proposed function of Est1 as an activator of telomerase (Taggart et al., 2002) . In this case, the KEOPS complex could act as a regulator or effector of this Est1 activity. However, despite the fact that such a role would easily explain the telomere length and healing phenotypes of bud32 or cgi121D mutants, it is less clear how the catalytic activity of telomerase can regulate telomere capping. Nevertheless, such a role for the telomerase complex has been previously proposed or implied (Chan and Blackburn, 2003; Teo and Jackson, 2001) and may be supported by our finding that deletion of PIF1, a gene encoding a catalytic inhibitor of telomerase (Boule et al., 2005) , potently suppress cdc13-1 (Figure 1 ). Therefore, this possibility cannot be ruled out until addressed experimentally.
Conservation of KEOPS Complex Components in Metazoans
In addition to Bud32 (PRPK) and Cgi121(hCGI-121), which are both well conserved in human cells, Kae1 (hOSGEP), but not Gon7, are also conserved across eukaryotes (Miyoshi et al., 2003; Seki et al., 2002) . This sequence conservation and the previously described PRPK/hCGI-121 interaction suggests that the architecture of the KEOPS complex may be evolutionarily conserved. Whether the KEOPS complex plays a role in human telomere-length homeostasis, capping regulation, or t loop function will form the core of our future investigations.
EXPERIMENTAL PROCEDURES
A detailed version of the Experimental Procedures has been included in the Supplemental Data in addition to two Supplemental Tables and eight Supplemental Figures.
Yeast Manipulation
All strains are derivatives of W303 or S288C as indicated in Table S2 . Yeast strains were constructed using standard genetic procedures either by genetic crosses or by homologous recombination. Cells were grown in supplemented minimal medium or in rich (XY) medium as indicated, to which glucose, raffinose, or raffinose plus galactose in variable proportions was added to a final concentration of 2%.
Synthetic Genetic Array
An S288C strain containing the cdc13-1 mutation flanked by URA3 and LEU2 markers (DLY2304) was mated into a set of $4800 haploid gene-deletion mutants and sporulated, germinated, and passaged essentially as previously described (Tong et al., 2001) . Haploid mutants containing gene-deletion mutants and the cdc13-1 point mutant were grown overnight at 20ºC in selective media in 96-well plates, and dilution series of each strain were spotted at permissive (23ºC), semipermissive (27.5-28ºC), and nonpermissive (37ºC) temperatures on rich media. Strains showing consistent growth at 23ºC and 27.5ºC but not 37ºC in both repetitions of the screen were prioritized for further study.
Quantitative Amplification of Single-Stranded DNA (QAOS) DNA from the indicated strain was prepared from frozen cell pellets, and real-time PCR ssDNA measurements and the primers/probes used were as previously described by Booth et al. (2001) .
Telomere-Healing Assays
Telomere-healing/GCR assays were done essentially as described in Kanellis et al. (2003) except that strains were streaked on synthetic media lacking uracil prior to inoculation of single colonies in 15 or 30 ml cultures. For telomere-healing assays following and HO endonuclease-induced DSB, strains were inoculated in SC-TRP-URA media containing 2% raffinose and grown to a concentration of 1-5 Â 10 6 cells/ml.
Galactose was added to a final concentration of 3% for 3.5 hr and then plated onto rich media. After 1-2 days, cells were replica plated onto a-aminoadipate plates lacking adenine to select for telomere-healing events (Bianchi et al., 2004) .
Telomerase Assays
Yeast extract preparations, telomerase crude purification, and in vitro telomerase assays were carried out essentially as described in Cohn and Blackburn (1995) .
Immunoprecipitations and Immunoblotting
Yeast protein extractions and immunoblotting were carried out in native or denaturing conditions exactly as described in Kanellis et al. (2003) . 
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